Agilent 1100 Series Analysis of Sulfa Drugs with HPLC Application Note

This document describes the HPLC separation method of five common sulfa drugs.

Brand: Analysis
Category: Other
Document type: Application Note
Language: English
Pages: 2
File format: PDF
File size: 45 KB
Published: 03 July, 2012
Updated: 30 September, 2023
Model: 1100 Series
MD5 checksum: 9133DFA2454263F4B74BC43945B30F76
PDF: Agilent 1100 Series Analysis of Sulfa Drugs with HPLC Application Note PDF

About this manual

This document details a High-Performance Liquid Chromatography (HPLC) method for separating and analyzing five common sulfa drugs: sulfanilamide, sulfadiazine, sulfathiazole, sulfamerazine, and sulfamethazine. The method utilizes a reversed-phase column with UV detection and gradient analysis.

What's inside

Abstract
Conditions
Equipment
Columns
Performance Table
Figure 1
Figure 2

Specifications

Column compartment temperature	50 °C
Injection volume	5 ul

Frequently asked questions

Which sulfa drugs are analyzed in this method?

The method analyzes sulfanilamide, sulfadiazine, sulfathiazole, sulfamerazine, and sulfamethazine.

What equipment is recommended for this analysis?

The method was specifically developed on the Agilent 1100 Series system.

What is the recommended column temperature?

The column compartment temperature should be set to 50 °C.

Download PDF (45 KB)